MIRA
INFORM REPORT
|
Report Date : |
10.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
DHARAMSHILA CANCER FOUNDATION AND RESEARCH CENTER |
|
|
|
|
Registered
Office : |
Dharamshila Marg, Vasundhara Enclave, Delhi – 110096 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
19.04.1990 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Not Available |
|
|
|
|
IEC No.: |
0593029810 |
|
|
|
|
TIN No.: |
07350231867 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAATD0451G |
|
|
|
|
Legal Form : |
Non- Government Voluntary Organization. |
|
|
|
|
Line of Business
: |
Caner Hospital. |
|
|
|
|
No. of Employees
: |
500 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established Non-government voluntary organisation
having satisfactory track. Trade relations are reported as fair. Payments are
reported to be usually correct and as per commitments. Initially. Subject can be considered normal for business dealings at
usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
|
|
|
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Praveen and Mr. Mittal |
|
Designation : |
Accounts Manager |
|
Contact No.: |
91-11-43066353/ 43066341 |
|
Date : |
09.08.2011 |
LOCATIONS
|
Registered Office : |
Dharamshila Marg, Vasundhara Enclave, Delhi – 110096, India |
|
Tel. No.: |
91-11-43066353/ 43066341 |
|
Fax No.: |
91-11-22617770/ 22619033/ 22618574 |
|
E-Mail : |
|
|
Website : |
MANAGEMENT
MEMBERS OF THE GOVERNING BODY
|
Name : |
Mr. Sudharshan Agarwal |
|
Designation : |
Patron |
|
Profile : |
Former Governor of Uttaranchal and Sikkim an d Secretary General of
Rajya Sabha |
|
|
|
|
Name : |
Mr. Anil Kumar |
|
Designation : |
President |
|
Profile : |
Chartered Accountant |
|
|
|
|
Name : |
Dr. S. Khanna |
|
Designation : |
Vice President and Treasurer |
|
Profile : |
Paediatrician |
|
|
|
|
Name : |
Mr. Prakash Akar |
|
Designation : |
Vice President |
|
Profile : |
Business Executive |
|
|
|
|
Name : |
Mr. Ravi Khanna |
|
Designation : |
Secretary |
|
Profile : |
Industrialist |
|
|
|
|
Name : |
Mr. N. S. Khanna |
|
Designation : |
Member |
|
Profile : |
Industrialist |
|
|
|
|
Name : |
Dr. R. Dawar |
|
Designation : |
Member |
|
Profile : |
Oncopathologist |
|
|
|
|
Name : |
Mr. Shanti Bhushan |
|
Designation : |
Member |
|
Profile : |
Sr. Advocate and Former, Law Minister |
|
|
|
|
Name : |
Mr. Sanjeev Shankar |
|
Designation : |
Member |
|
Profile : |
Solicitor |
|
|
|
|
Name : |
Mr. Jai Dev Kapoor |
|
Designation : |
Member |
|
Profile : |
Industrialist |
|
|
|
|
Name : |
Mr. S. P. Jain |
|
Designation : |
Member |
|
Profile : |
Chartered Accountant |
|
|
|
|
Name : |
Ms. Jyoti Khanna |
|
Designation : |
Member |
|
Profile : |
Entrepreneur |
|
|
|
|
Name : |
Ms. Krishna Sharma |
|
Designation : |
Member |
|
Profile : |
Social Worker |
|
|
|
|
Name : |
Mr. Jaywant Singh |
|
Designation : |
Member |
|
Profile : |
Business Executive |
KEY EXECUTIVES
|
Name : |
Mr. Praveen and Mr. Mittal |
|
Designation : |
Accounts Manager |
BUSINESS DETAILS
|
Line of Business : |
Caner Hospital. |
|
|
|
|
Imports : |
|
|
Products : |
Equipments, Instruments and Medicines. |
|
Countries : |
All over the world |
|
|
|
|
Terms : |
|
|
Selling : |
Cash and Credit (30 days) |
|
|
|
|
Purchasing : |
L/C, Cash and Credit (30 days) |
GENERAL INFORMATION
|
Customers : |
End Users |
|
|
|
|
No. of Employees : |
500 (Approximately) |
|
|
|
|
Bankers : |
· Corporation Bank Mayor Vihar, Delhi, India · Axis Bank Limited Mayor Vihar, Delhi, India |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
Not Available |
CAPITAL STRUCTURE
|
Capital Investment : |
|
|
Owned : |
Not Available |
|
Borrowed : |
Not Available |
|
Total : |
-- |
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
|
|
31.03.2011 |
|
Sales Turnover (Approximately) |
|
|
500.000 |
|
|
|
|
|
The above information has been parted by Mr. Praveen and Mr. Mittal.
LOCAL AGENCY FURTHER INFORMATION
WEBSITE DETAILS:
A group of concerned relatives and friends of cancer
patients felt the need to provide complete cancer treatment under one roof. They
felt it was their Dharma (duty) to provide to cancer patients what was not
available to their near and dear ones when they suffered with cancer. They laid
the Shila (foundation) of their duty by registering a non-government voluntary
organization - Dharamshila Cancer Foundation and Research Centre (DCFRC) on 19
April 1990, with the sole objective of making cancer treatment available,
accessible and affordable. DCFRC Commissioned the first phase of the hospital
with 100 beds in 1994 and expanded to 300 beds in 2006.
DHRC provides preventive, diagnostic, therapeutic,
rehabilitative, palliative and support services under one roof. Responding to
the healthcare needs of the community all other allied services like
Neurosurgery, Cosmetic and Plastic Surgery, Dental and Faciomaxillary Surgery,
Orthopaedics, Gastroenterology, Nephrology and Urology etc. were added.
DHRC is continuously adding cutting edge technologies, practicing evidence based
medicine and following international treatment protocols, to achieve best
treatment outcomes.
High quality standards of treatment, complete patient safety and satisfaction,
improving cure rates and adding quality to life will always be our hallmark.
The hospital has evolved into North India's premier cancer institute, treating
all types of cancers and is one of the first to explore gene therapy.
Being sensitive to the physical, medical, emotional and financial needs of the
patients, DHRC serves them with love, devotion, compassion, commitment and
positive attitude.
Transparent and honest billing policies and above mentioned factors have helped
us to win our patients and expand our referral base to all over India and
Neighboring countries.
To add to the pool of trained and skilled manpower, we were first in India to
start three years full time doctorate course - DNB Medical Oncology in 2002,
DNB Surgical Oncology in 2003 and Post Basic Diploma in Oncology Nursing in
2010.
ACHIEVEMENTS
A few pioneering steps:
First and Only Cancer Hospital of Delhi, offering Third
Generation Radiation Technology i.e. Elekta Synergy VMAT with IMRT, IGRT, SBRT
and SRS / SRT and Respiratory Gating Capabilities and best Treatment Planning
systems like Monaco, CMSxi0, ERGO++ and Plato.
First and only cancer hospital in India accredited by National Accreditation Board for Hospitals
and Healthcare Providers (NABH).
First cancer hospital in North India accredited by National Accreditation Board for Testing and
Calibration Laboratories (NABL).
First cancer hospital in India, certified for implementing
integrated quality and environment management systems conforming to ISO 9001:2008 and ISO 14001:2004 standards by TUV-NORD,
Germany.
First hospital in India, given accreditation by National Board of Examination (NBE)
for the Diplomate National Board (DNB) Programme in medical and surgical
oncology.
First Cancer Hospital of North India to Start Post Basic Diploma in Oncology Nursing (PBDON).
Trained First Medical Oncologist of India trained in DNB -
Medical Oncology (2001-2004)
MILESTONES
|
Date |
Mile stones |
|
07.01.2011 |
DHRC is now offering Third Generation Radiation Technology
i.e. Elekta Synergy VMAT with IMRT, IGRT, SBRT and SRS / SRT and Respiratory
Gating Capabilities and best Treatment Planning systems like Monaco, CMSxi0,
ERGO++ and Plato. |
|
29 - 30.09.2010 |
2nd Annual Surveillance Audit of QMS (ISO
9001:2000) & upgradation of ISO 9001:2008 and EMS (ISO 14001:2004) |
|
09.09.2010 |
Laboratory Services of Dharamshila Hospital And Research
Centre is now Accredited by National
Accreditation Board for Testing and Calibration Laboratories (NABL) for
Medical Testing in the fields of Clinical Biochemistry, Clinical Pathology,
Haematology amd Immunohaematology, Microbiology & Serology,
Histopathology and Cytopathology as per the Standard ISO 15189 : 2007.
Certificate No. M - 0257 |
|
22.11.2008 |
Accredited by the National Accreditation Board for
hospitals and Health Care Provides (NABH). |
|
04.11.2008 |
Re-certified by TUV Germany, for implementing integrated
quality and environmental management systems as per ISO 9001:2000 and ISO
14001:2004 standards. |
|
20.10.2007 |
Inauguration of new facilities titled “Samvardhan” by the
Hon’ble Chief Minister of Delhi, Smt. Shiela Dixit. |
|
09.10.2007 |
Changed the name of Dharamshila Cancer Hospital And
Research Centre (DCHRC) to Dharamshila Hospital and Research Centre (DHRC). |
|
26.09.2005 |
Installation of second linear accelerator. |
|
20.08.2005 |
Replacement of the old Gamma camera with a new one from
G.E. |
|
01.07.2005 |
Enrolled two students, Dr. Gagandeep Singh for DNB Surgical
Oncology and Dr. Varsha for DNB Radiation Oncology. |
|
25.04.2005 |
Construction of the new hospital building started. |
|
21.11.2004 |
Laid foundation stone of the new building for additional
facilities. |
|
20.11.2004 |
Dr. Meenu Walia, first student of India, passed DNB
Medical Oncology from DCHRC. |
|
05.08.2004 |
Enrolled first batch of student of Radiation Oncology. |
|
01.07.2004 |
Celebrated 10th anniversary of the hospital. |
|
16.06.2004 |
Upgraded Endoscopy Suite with state-of-the-art video
endoscopes, video colonoscope and colposcope. |
|
16.06.2004 |
Upgraded blood bank with Heraeus deep freeze and cold room
facility with storage capacity of 8000 FFP units and 2000 blood unit. |
|
05.08.2004 |
Given accreditation by National Board of Examination to
start Diplomate National Board (DNB) in Surgical Oncology and Radiation
Oncology. |
|
17.09.2003 |
Installed high speed NXI digital dual slice CT Scanner. |
|
30.11.2002 |
Free Palliative Home care project started in collaboration
with CAN Support. |
|
28.10.2002 |
Hon. President of India, Dr. Abdul Kalam visited hospital
and inaugurated the linear accelerator. |
|
11.10.2002 |
Certified by TUV Germany, for implementing integrated
quality and environmental management systems as per ISO 9001:2000 and ISO
14001:1996 standards. |
|
30.08.2002 |
Installed, state-of-the-art digital, dual energy, Linear
Accelerator and Eclips 3D treatment planning system. |
|
11.08.2001 |
Installed one of the most advanced ultrasound machines
with colour doppler capability, the “LOGIQ 500 PRO” series from GE. |
|
01.07.2001 |
Given accreditation by National Board of Examination to
start Diplomate National Board (DNB) in Medical Oncology. |
|
18.05.2000 |
Launch of website. The site provided an introduction to
the hospital, the facilities available and also the details of Dharamshila
Cancer Rahat Yojana. |
|
02.02.2000 |
“Talented Ladies Award for Human Care and Services” awarded
to Dr. S. Khanna by the Mayor of Delhi, Mrs. Meera Kanwaria |
|
10.01.2000 |
DCFRC was awarded prestigious membership of International
Union against cancer – a global union of institutions, fighting against
cancer. |
|
29.12.1999 |
“Millennium Award to Intellectuals and Thinkers” awarded
to Dr. S. Khanna by the Ambassador of China. |
|
20.12.1999 |
"Human Care Award of the Millennium" awarded to
Dr. S. Khanna by Chief Minister of Delhi, Smt. Shiela Dikshit. |
|
23.10.1999 |
Dharamshila Cancer Rahat Yojana, a cancer insurance scheme
launched by Hon. Health Minister, Shri A.K. Walia. |
|
10.08.1999 |
Inauguration of Nuclear Medicine Dept. and TMT. |
|
08.09.1998 |
Inauguration of spiral CT scanner by Chief Minister of Delhi,
Shri Sahib Singh Verma. |
|
30.08.1997 |
Inauguration of Microselectron HDR with Plato treatment
planning system and Rehabilitation Dept. by Lt. Governor Shri Tajendra
Khanna. |
|
30.08.1996 |
Purchased 5060 sqmt. of additional land for future expansion.
|
|
30.08.1995 |
Inauguration of leukemia wing, blood bank with blood cell
separator by Shri P.K. Dave, Lt. Governor of Delhi and Shri Madan Lal
Khurana, Chief Minister of Delhi |
|
03.10.1994 |
Mammography machine installed. |
|
30.08.1994 |
First major surgery performed |
|
01.07.1994 |
Commissioning of the first phase of the hospital with 100
beds. |
|
30.08.1993 |
Greeting card division started for raising funds for the
hospital building. |
|
01.07.1992 |
Construction of North India’s first comprehensive cancer
care centre started. |
|
30.06.1992 |
Architectural plans for 300-bed cancer hospital approved
by DDA. |
|
30.08.1991 |
Foundation stone of the hospital laid by Minister of
Health and Family Welfare Shri M.L. Fotedar, and Shri Sunil Dutt (Cine Star).
|
|
06.12.1990 |
Possession of 8097 sqmt. of land taken from Delhi
Development Authority (DDA). |
|
19.4.1990 |
Registration of DCFRC as a NGO under Society’s
Registration Act XXI of 1860 |
NEWS
AND EVENTS:
DHRC NEWS
Clinical Training on Elekta Synergy
CLINICAL RADIATION ONCOLOGY TRAINING AT MANNHEIM MEDICAL
CENTRE, GERMANY
Dharamshila Hospital and Research Centre has recently acquired
a new Elekta Synergy Linear Accelerator capable of IMRT, IGRT, SRS, SRT and
SBRT. The clinical and technical application training of this machine is
usually scheduled at a teaching Hospital in Germany. Dr. Hari Mohan, Consultant
- Radiation Oncology, Dharamshila Hospital visited Mannheim Medical Centre,
Germany for clinical training on Elekta Synergy.
Mannheim Medical Centre, Germany is affiliated to University of Heidelberg,
Germany, the oldest university of Germany. The department of Radiation Oncology
at this hospital is equipped with CT simulator, 3 Linear Accelerators,
intraoperative Brachytherapy for breast, head and neck and pelvic tumors and
interstitial Brachytherapy with iodine seeds for prostate cancer.
He has received a first hand experience of treatment planning with VMAT on
Monaco planning system. It was enlightening to know the protocols and planning
methodology being used at this centre. All the patients undergo CT simulation
as a routine and are planned for radiotherapy with utmost care and compassion.
Respiratory gating is used for tumors of lung, breast and chest wall.
The treatment is planned with Oncentra Masterplan, for 3D-conformal
radiotherapy and with 5 different inverse treatment planning systems (Corvus,
Oncentra Masterplan and preciseplan exclusively for static IMRT, Ergo+++ for
VMAT treatments and Monaco for both static and VMAT treatments).
He saw IGRT being performed with stereotactic ultrasound and with X-ray volume
imaging (Cone Beam CT, Elekta XVI on Elekta synergy).
Treatments were recorded with the MOSAIQ electronic Medical Record (EMR) of the
patient. MOSAIQ oncology PACS archives all critical data.
IMRT was used for the treatment of almost all patients of Head and neck,
prostate and stomach. Tumor relapses near the spine were also treated with
IMRT. IGRT protocols are strictly followed for all IMRT patients.
He got experience in Extracranial frameless SRT with image guidance (IGRT). In
addition, LDR brachytherapy for prostate cancer is also available.
The department actively collaborates with other departments within the
framework of Comprehensive Cancer Centre. This was very similar to the tumor
board meeting which we routinely conduct at our hospital wherein every new
cancer patient's management plan collaboratively is arrived at after a joint
meeting with Radiation, Medical and surgical oncologists together with
oncopathologist and imaging oncology experts.
We at Dharamshila Hospital, have the same setup for Radiotherapy treatment and
planning. In addition, we also have Nucletron HDR Brachytherapy facilities
which are not there at Mannheim Medical Centre. It is indeed a pleasure to
realize that we have the same world class technology which is available at most
of the top institutes all over the world. We have been treating our patients
with IMRT for the last 6 years and IGRT with VMAT is also now fully functional.
That brings us at par with some of the best Radiotherapy departments across the
globe. And we sincerely hope that the treatment outcome of our cancer patients
will now also be at par with the best internationally accepted standards.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.17 |
|
|
1 |
Rs.73.72 |
|
Euro |
1 |
Rs.64.26 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.